Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Akouos reveals lead program for sensorineural hearing loss

Sep. 16, 2019

First patient randomized in phase II study of AM-125 for the treatment of acute vertigo

July 31, 2019

Phase IIb study of SPI-1005 in Meniere's disease meets endpoints

June 26, 2019

TNF and tinnitus

June 26, 2019

Sensorion signs hearing loss research partnership framework agreement with Institut Pasteur

May 27, 2019

DSMB recommends continuation of phase II study of SENS-111 in acute unilateral vestibulopathy

May 15, 2019

Phase I results for OP-0201 in healthy adults and adults with acute otitis media

April 23, 2019

Initiation of phase I/II study of OTO-313 in patients with tinnitus

April 12, 2019

Frequency Therapeutics reports phase I/II data on FX-322 for hearing restoration

April 9, 2019

Hearing loss gene therapy works in adult mice

March 12, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...